M-40403 Metaphore Pharmaceuticals

IDrugs. 2005 Jan;8(1):67-76.

Abstract

Metaphore Pharmaceuticals Inc. is developing M-40403, a superoxide dismutase mimetic, for the potential treatment of pain, dermatological disease and inflammation. The company is also investigating the compound for its potential in the treatment for the side effects associated with chemotherapy and radiation therapy.

Publication types

  • Review

MeSH terms

  • Analgesics / chemistry
  • Analgesics / therapeutic use
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / chemistry
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Drugs, Investigational / chemistry
  • Drugs, Investigational / therapeutic use*
  • Free Radical Scavengers / chemistry
  • Free Radical Scavengers / therapeutic use
  • Humans
  • Manganese
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / therapeutic use*
  • Technology, Pharmaceutical / methods*
  • Technology, Pharmaceutical / trends

Substances

  • Analgesics
  • Anti-Inflammatory Agents, Non-Steroidal
  • Drugs, Investigational
  • Free Radical Scavengers
  • Organometallic Compounds
  • imisopasem manganese
  • Manganese